Canada markets closed

Galectin Therapeutics Inc. (GALT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.2300+0.0900 (+2.87%)
At close: 04:00PM EDT
3.2700 +0.04 (+1.24%)
After hours: 04:56PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 200.74M
Enterprise Value 261.92M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)207.70
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -4.04

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 377.47%
S&P500 52-Week Change 326.49%
52 Week High 34.2700
52 Week Low 31.2800
50-Day Moving Average 33.0038
200-Day Moving Average 32.1209

Share Statistics

Avg Vol (3 month) 3183.88k
Avg Vol (10 day) 3165.84k
Shares Outstanding 562.15M
Implied Shares Outstanding 662.15M
Float 842.72M
% Held by Insiders 131.12%
% Held by Institutions 112.30%
Shares Short (Apr 30, 2024) 43.12M
Short Ratio (Apr 30, 2024) 410.29
Short % of Float (Apr 30, 2024) 410.54%
Short % of Shares Outstanding (Apr 30, 2024) 45.04%
Shares Short (prior month Mar 28, 2024) 42.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Mar 23, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-96.17%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-44.8M
Diluted EPS (ttm)-0.7400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.66M
Total Cash Per Share (mrq)0.41
Total Debt (mrq)71.81M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.77
Book Value Per Share (mrq)-1.01

Cash Flow Statement

Operating Cash Flow (ttm)-32.97M
Levered Free Cash Flow (ttm)-20.68M